Page last updated: 2024-08-24

naxagolide and MPTP Neurotoxicity Syndrome

naxagolide has been researched along with MPTP Neurotoxicity Syndrome in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guillén, J; Laguna, J; Luquin, MR; Martínez-Lage, JM; Martínez-Vila, E	1
Herrero, MT; Laguna, J; Luquin, MR; Obeso, JA	1
Cruz Rodriguez, M; Del Rio, L; Dominguez, J; Guillén, J; Legarda, I; Luquin, MR; Martínez-Lage, JM	1
Foster, AC; Hill, RG; Iversen, L; Iversen, SD; Kemp, JA; Leeson, PD; Rupniak, NM; Saywell, K; Tricklebank, MD; Williams, BJ	1
Bédard, PJ; Gomez-Mancilla, B	1
Lawrence, MS; Redmond, DE	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, S	1

Reviews

1 review(s) available for naxagolide and MPTP Neurotoxicity Syndrome

Article	Year
Neurotoxin-related research: from the laboratory to the clinic. Annals of the New York Academy of Sciences, 1992, May-11, Volume: 648 Topics: Animals; Antiparkinson Agents; Dopamine Agents; Humans; Levodopa; Mice; MPTP Poisoning; Nervous System; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Prodrugs; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Saimiri	1992

Other Studies

6 other study(ies) available for naxagolide and MPTP Neurotoxicity Syndrome

Article	Year
Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys. European journal of pharmacology, 1994, Mar-03, Volume: 253, Issue:3 Topics: Animals; Benzazepines; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Indoles; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride	1994
Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys. Journal of the neurological sciences, 1993, Volume: 114, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agents; Drug Tolerance; Female; Macaca fascicularis; Male; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Psychomotor Performance	1993
Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys. Advances in neurology, 1996, Volume: 69 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Dopamine Agents; Dopamine Agonists; Drug Tolerance; Female; Indoles; Macaca fascicularis; Male; Movement; MPTP Poisoning; Oxazines; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2	1996
Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys. Experimental neurology, 1992, Volume: 117, Issue:2 Topics: Animals; Antiparkinson Agents; Dopamine Agents; Female; Indoles; Macaca fascicularis; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2	1992
MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4 Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poisoning; Oxazines; Parkinson Disease; Receptors, Dopamine; Substantia Nigra; Sulpiride	1991
Modulatory role for CCK-B antagonists in Parkinson's disease. Clinical neuropharmacology, 1990, Volume: 13, Issue:4 Topics: Animals; Benzodiazepinones; Carbidopa; Cholecystokinin; Devazepide; Dopamine Agents; Levodopa; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenylurea Compounds; Receptors, Cholecystokinin; Saimiri	1990